[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-370533-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-370533-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-contribution-of-coding-variants-to-the-heritability-of-multiple-cancer-types-using-uk-biobank-whole-exome-sequencing-data","The contribution of coding variants to the heritability of multiple cancer types using UK Biobank whole-exome sequencing data","","Rare coding variants contribute to inherited cancer risk, but their overall share of cancer heritability is not well defined. A method is presented to estimate genome-wide contributions of rare coding variants using an empirical Bayesian approach that fits burden effect sizes, applied to protein-truncating variants across over 15,000 genes for 11 cancers in the UK Biobank. Using whole-exome sequencing data from 400,000+ individuals, gene overlap is extended to cancer pairs. Results show ovarian cancer has the largest heritability proportion from protein-truncating variants (46%) and reveal near-complete overlap among breast, ovarian, prostate, and pancreatic susceptibility genes, identifying additional multi-cancer genes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-contribution-of-coding-variants-to-the-heritability-of-multiple-cancer-types-using-uk-biobank-whole-exome-sequencing-data/370533/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-contribution-of-coding-variants-to-the-heritability-of-multiple-cancer-types-using-uk-biobank-whole-exome-sequencing-data/370533.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-21","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address about cancer heritability?","Question",{"text":63,"@type":64},"Common-variant GWAS findings do not explain all inherited cancer risk. The study focuses on quantifying how much rare coding variants contribute to cancer heritability across multiple cancer types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is the contribution of rare coding variants estimated?",{"text":68,"@type":64},"The method fits models to burden effect sizes using an empirical Bayesian approach, then applies it to protein-truncating variants using UK Biobank whole-exome sequencing data.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancers and gene overlaps are highlighted by the results?",{"text":72,"@type":64},"Ovarian cancer shows the greatest proportion of heritability attributable to protein-truncating variants in genes (46%). Joint cancer models reveal near-complete overlap in susceptibility genes for breast, ovarian, prostate, and pancreatic cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},370533,1790216126,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","The contribution of coding variants to the heritability of multiple cancer types using UK Biobank whole-exome sequencing data  \nAuthors  \nNaomi Wilcox, Jonathan P. Tyrer, Joe Dennis, Xin Yang, John R.B. Perry, Eugene J. Gardner, Douglas F. Easton  \nCorrespondence  \n[senior_naomi@yahoo.com](senior_naomi@yahoo.com)  \nWe developed a method to estimate the contribution of rare coding variants to cancer heritability and applied it to 11 cancers in the UK Biobank. Our results provide insights into the contribution of genes to multiple cancers. We identify a nearcomplete overlap of genes for breast, ovarian, prostate, and pancreatic cancer.  \nWilcox et al., 2025, The American Journal of Human Genetics 112, 903–912 April 3, 2025 Crown Copyright 􀀁 2025 Published by Elsevier Inc. on behalf of American Society of Human Genetics.  \n[https://doi.org/10.1016/j.ajhg.2025.02.013](https://doi.org/10.1016/j.ajhg.2025.02.013)  \nll  \nThe contribution of coding variants to the heritability of multiple cancer types using UK Biobank whole-exome sequencing data  \nNaomi Wilcox, 1,* Jonathan P. Tyrer,1 Joe Dennis, 1 Xin Yang, 1 John R.B. Perry,2,3 Eugene J. Gardner,3  \nand Douglas F. Easton 1,4 Summary  \nGenome-wide association studies have been highly successful at identifying common variants associated with cancer; however, they do not explain all the inherited risks of cancer. Family-based studies, targeted sequencing, and, more recently, exome-wide association studies have identiﬁed rare coding variants in some genes associated with cancer risk, but the overall contribution of these variants to the heritability of cancer is less clear. Here, we describe a method to estimate the genome-wide contribution of rare coding variants to heritability that ﬁts models to the burden effect sizes using an empirical Bayesian approach. We apply this method to the burden of protein-truncating variants in over 15,000 genes for 11 cancers in the UK Biobank using whole-exome sequencing data on over 400,000 individuals. We extend the method to consider the overlap of genes contributing to pairs of cancers. We found ovarian cancer to have the greatest proportion of heritability attributable to protein-truncating variants in genes (46%). The joint cancer models highlight signiﬁcant clustering of cancer types, including a near-complete overlap in susceptibility genes for breast, ovarian, prostate, and pancreatic cancer. Our results provide insights into the contribution of rare coding variants to the heritability of cancer and identify additional genes with strong evidence of susceptibility to multiple cancer types.  \nIntroduction  \nGenome-wide association studies (GWASs) have been highly successful at identifying common variants associated with disease. Increasingly, association studies are being extended to study rare variants using next-generation sequencing methods. For example, for breast cancer (MIM: 114480), GWASs have identiﬁed over 300 common  \nsusceptibility loci,1–3 while rare variants in ATM (MIM: 607585), BARD1 (MIM: 601593), BRCA1 (MIM: 113705), BRCA2 (MIM: 600185), CHEK2 (MIM: 604373), RAD51C (MIM: 602774), RAD51D (MIM: 602954), PALB2 (MIM: 610355), and TP53 (MIM: 191170) have been identiﬁed through linkage or targeted sequencing studies.4 Exomewide analysis has recently additionally identiﬁed rare variants in MAP3K1 (MIM: 600982) to be associated with breast cancer risk.5 Similarly, for bowel cancer (MIM: 114500), GWASshave identiﬁed over 200 common susceptibility loci,6 and rare variants have been identiﬁed in mismatch repair (MMR) genes including MSH2 (MIM: 609309), MSH6 (MIM: 600678), MLH1 (MIM: 120436), and PMS2 (MIM: 600259), as well other genes including APC7 (MIM: 611731) . The increasing availability of whole-exome sequencing (WES) and whole-genome sequencing data is enabling exome- and genome-wide analysis of rare variants and the discovery of novel rare variants associated with cancer risk.  \nFor common variants, GWAS data can be used to estimat","cbCaioZgtuuRv9Lj","https://ap.wps.com/l/cbCaioZgtuuRv9Lj","pdf",1905956,11,"English","# Summary\n# Introduction\n## Background on common variants and GWAS\n## Rare variant evidence from sequencing studies\n## Prior gene-burden heritability methodology\n# Methods and analysis approach\n## Empirical Bayesian burden effect estimation\n## Extension to overlapping genes across cancer pairs\n# Findings\n## Ovarian cancer heritability contribution from protein-truncating variants\n## Clustering and near-complete gene overlap across cancer types\n# Implications\n## Identifying multi-cancer susceptibility genes","[{\"question\":\"What problem does the study address about cancer heritability?\",\"answer\":\"Common-variant GWAS findings do not explain all inherited cancer risk. The study focuses on quantifying how much rare coding variants contribute to cancer heritability across multiple cancer types.\"},{\"question\":\"How is the contribution of rare coding variants estimated?\",\"answer\":\"The method fits models to burden effect sizes using an empirical Bayesian approach, then applies it to protein-truncating variants using UK Biobank whole-exome sequencing data.\"},{\"question\":\"Which cancers and gene overlaps are highlighted by the results?\",\"answer\":\"Ovarian cancer shows the greatest proportion of heritability attributable to protein-truncating variants in genes (46%). Joint cancer models reveal near-complete overlap in susceptibility genes for breast, ovarian, prostate, and pancreatic cancer.\"}]","The contribution of coding variants to the heritability of multiple cancer types using UK Biobank whole-exome sequencing data | PDF",1790189022,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb243e82181bf7ac335c233b535a3eb3.webp",983,1276,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b4b6ba016ca2e55c08770611a0725307.webp",982,1275,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6f34f24bea229d25c67442e066d4a28.webp",981,1273,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/033f9ca474c6dceb7aeeb6ee2d663073.webp",980,1272]